MedTrace Logo

Effectiveness of the American Lung Association Reactive Anti-Smoking Telephone Help Line in Illinois

NCT00749151 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 990

Last updated 2010-11-18

No results posted yet for this study

Summary

An estimated 47 million adult Americans smoke. The American Lung Association has launched a reactive telephone help line to assist in smoking cessation. The proposed study will evaluate its effectiveness in a randomized controlled trial design involving active smokers who call this helpline. Eligible callers will be randomized into two groups: those who receive self-help literature only (i.e. control group) and those who receive additional reactive telephone counseling (i.e. study group). Detailed information will be collected proactively by an independent research calling specialist from all subjects who enroll into the study, by way of follow-up telephone calls, at one, three, six and twelve months following the screen date. The outcome measures to be compared are abstinence rates, quit attempts, changes in extent of smoking and behavioral stage, and cost-effectiveness. A thousand subjects will be enrolled in the two study arms in equal numbers over a period of fifteen months. Intent to treat analysis will be used after adjustment for covariates. The significance of this study lies in establishing the public health importance of such a reactive telephone helpline as a low intensity and low cost interventional smoking cessation tool.

Conditions

  • Smoking

Interventions

BEHAVIORAL

telephone counseling

First time callers to telephone help line agreed to one year follow-up on smoking cessation.

Sponsors & Collaborators

  • American Lung Association

    collaborator OTHER

  • Southern Illinois University

    lead OTHER

Principal Investigators

  • Akshay Sood, MD, MPH · SIU School of Medicine

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-12-31
Primary Completion
2007-02-28
Completion
2007-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00749151 on ClinicalTrials.gov